This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2012 Mar 22;155(3):482-3.

doi: 10.1016/j.ijcard.2011.12.070. Epub 2012 Jan 10.

ARB may be superior to ACEI on treatment of Marfan's syndrome by blocking TGF-β mediated activation of ERK

Yang Yang, Yi Cui, Dao-Quan Peng

PMID: 22236512
DOI: 10.1016/j.ijcard.2011.12.070

ARB may be superior to ACEI on treatment of Marfan's syndrome by blocking TGF-β mediated activation of ERK

Yang Yang et al. Int J Cardiol. 2012.

. 2012 Mar 22;155(3):482-3.

doi: 10.1016/j.ijcard.2011.12.070. Epub 2012 Jan 10.

Authors

Yang Yang, Yi Cui, Dao-Quan Peng

PMID: 22236512
DOI: 10.1016/j.ijcard.2011.12.070

No abstract available

PubMed Disclaimer

Similar articles

Medicine. Frightening risk of Marfan syndrome, and potential treatment, elucidated.
Couzin-Frankel J. Couzin-Frankel J. Science. 2011 Apr 15;332(6027):297. doi: 10.1126/science.332.6027.297. Science. 2011. PMID: 21493836 No abstract available.
Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.
Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC 3rd. Brooke BS, et al. N Engl J Med. 2008 Jun 26;358(26):2787-95. doi: 10.1056/NEJMoa0706585. N Engl J Med. 2008. PMID: 18579813 Free PMC article. Clinical Trial.
Angiotensin II blockade in Marfan's syndrome.
Ahimastos AA, Dart AM, Kingwell BA. Ahimastos AA, et al. N Engl J Med. 2008 Oct 16;359(16):1732; author reply 1733-4. doi: 10.1056/NEJMc081528. N Engl J Med. 2008. Retraction in: N Engl J Med. 2015 Dec 3;373(23):2280. doi: 10.1056/NEJMe1514259. PMID: 18923178 Retracted. No abstract available.
[Anti-hypertensive treatment in metabolic syndrome--focus on ARB or ACE inhibitor].
Yano Y, Kario K. Yano Y, et al. Nihon Rinsho. 2011 Jan;69 Suppl 1:576-81. Nihon Rinsho. 2011. PMID: 21766663 Review. Japanese. No abstract available.
Angiotensin receptor blockers: a panacea for Marfan syndrome and related disorders?
Loeys BL. Loeys BL. Drug Discov Today. 2015 Feb;20(2):262-6. doi: 10.1016/j.drudis.2014.09.022. Epub 2014 Oct 2. Drug Discov Today. 2015. PMID: 25281853 Review.

See all similar articles

Cited by

Update in the management of aortic dissection.
Tolenaar JL, van Bogerijen GH, Eagle KA, Trimarchi S. Tolenaar JL, et al. Curr Treat Options Cardiovasc Med. 2013 Apr;15(2):200-13. doi: 10.1007/s11936-012-0226-1. Curr Treat Options Cardiovasc Med. 2013. PMID: 23307603
The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension.
Huang Z, Cao J, Yao Y, Jin X, Luo Z, Xue Y, Zhu C, Song Y, Wang Y, Zou Y, Qian J, Yu K, Gong H, Ge J. Huang Z, et al. Ann Transl Med. 2020 Apr;8(7):430. doi: 10.21037/atm.2020.03.229. Ann Transl Med. 2020. PMID: 32395474 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal